SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Avanos Medical, Inc. – ‘10-K’ for 12/31/23 – ‘EXCEL’

On:  Tuesday, 2/20/24, at 6:33pm ET   ·   As of:  2/21/24   ·   For:  12/31/23   ·   Accession #:  1606498-24-18   ·   File #:  1-36440

Previous ‘10-K’:  ‘10-K’ on 2/21/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   18 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/21/24  Avanos Medical, Inc.              10-K       12/31/23  114:10M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.13M 
 2: EX-19.1     Amended and Restated Policy on Insider Trading and  HTML     68K 
                Tipping                                                          
 3: EX-21       Subsidiaries of the Corporation                     HTML     35K 
 4: EX-23       Consent of Independent Registered Public            HTML     30K 
                Accounting Firm                                                  
 5: EX-24       Powers of Attorney                                  HTML     39K 
10: EX-97.1     Incentive Compensation Clawback Policy              HTML     50K 
 6: EX-31.A     Section 302 CEO Certification                       HTML     34K 
 7: EX-31.B     Section 302 CFO Certification                       HTML     34K 
 8: EX-32.A     Section 906 CEO Certification                       HTML     31K 
 9: EX-32.B     Section 906 CFO Certification                       HTML     31K 
16: R1          Cover                                               HTML     97K 
17: R2          Audit Information                                   HTML     35K 
18: R3          Consolidated Income Statements                      HTML    123K 
19: R4          Consolidated Statements of Comprehensive Income     HTML     59K 
                (Loss)                                                           
20: R5          Consolidated Balance Sheets                         HTML    148K 
21: R6          Consolidated Balance Sheets (Parenthetical)         HTML     45K 
22: R7          Consolidated Statement of Stockholders? Equity      HTML     88K 
23: R8          Consolidated Cash Flow Statements                   HTML    119K 
24: R9          Accounting Policies                                 HTML     61K 
25: R10         Discontinued Operations                             HTML     81K 
26: R11         Restructuring                                       HTML     55K 
27: R12         Goodwill                                            HTML     40K 
28: R13         Supplemental Balance Sheet Information              HTML    101K 
29: R14         Business Acquisitions                               HTML     76K 
30: R15         Leases                                              HTML     60K 
31: R16         Fair Value Information                              HTML     52K 
32: R17         Debt                                                HTML     64K 
33: R18         Income Taxes                                        HTML    110K 
34: R19         Employee Benefit Plans                              HTML     37K 
35: R20         Accumulated Other Comprehensive Income              HTML     59K 
36: R21         Stock-Based Compensation                            HTML     86K 
37: R22         Commitments and Contingencies                       HTML     40K 
38: R23         Earnings Per Share ("Eps")                          HTML     61K 
39: R24         Business and Products Information                   HTML     66K 
40: R25         Share Repurchase Program                            HTML     46K 
41: R26         Accounting Policies (Policies)                      HTML     98K 
42: R27         Discontinued Operations (Tables)                    HTML     79K 
43: R28         Restructuring (Tables)                              HTML     49K 
44: R29         Goodwill (Tables)                                   HTML     42K 
45: R30         Supplemental Balance Sheet Information (Tables)     HTML    126K 
46: R31         Business Acquisitions (Tables)                      HTML     75K 
47: R32         Leases (Tables)                                     HTML     63K 
48: R33         Fair Value Information (Tables)                     HTML     48K 
49: R34         Debt (Tables)                                       HTML     50K 
50: R35         Income Taxes (Tables)                               HTML    108K 
51: R36         Accumulated Other Comprehensive Income (Tables)     HTML     59K 
52: R37         Stock-Based Compensation (Tables)                   HTML     88K 
53: R38         Earnings Per Share ("Eps") (Tables)                 HTML     59K 
54: R39         Business and Products Information (Tables)          HTML     81K 
55: R40         Share Repurchase Program (Tables)                   HTML     41K 
56: R41         Accounting Policies - Property, Plant and           HTML     41K 
                Equipment and Depreciation (Details)                             
57: R42         Accounting Policies - Goodwill and Other            HTML     44K 
                Intangible Assets (Details)                                      
58: R43         Accounting Policies - Revenue Recognition and       HTML     60K 
                Accounts Receivable (Details)                                    
59: R44         Accounting Policies - Income Taxes (Details)        HTML     32K 
60: R45         Discontinued Operations - Narratives (Details)      HTML     59K 
61: R46         Discontinued Operations - Summary of Income         HTML     61K 
                (Details)                                                        
62: R47         Discontinued Operations - Summary of Balance Sheet  HTML     65K 
                (Details)                                                        
63: R48         Discontinued Operations- Summary of Cashflow        HTML     41K 
                (Details)                                                        
64: R49         Restructuring - Restructuring Expense (Details)     HTML     41K 
65: R50         Restructuring - Narrative (Details)                 HTML     61K 
66: R51         Restructuring - Accrual and Payment Activity        HTML     39K 
                (Details)                                                        
67: R52         Goodwill - Narrative (Details)                      HTML     32K 
68: R53         Goodwill - Summary of Goodwill (Details)            HTML     47K 
69: R54         Supplemental Balance Sheet Information - Accounts   HTML     49K 
                receivable (Details)                                             
70: R55         Supplemental Balance Sheet Information -            HTML     40K 
                Inventories (Details)                                            
71: R56         Supplemental Balance Sheet Information - Narrative  HTML     39K 
                (Details)                                                        
72: R57         Supplemental Balance Sheet Information - Property,  HTML     57K 
                Plant and Equipment (Details)                                    
73: R58         Supplemental Balance Sheet Information -            HTML     46K 
                Intangible Assets (Details)                                      
74: R59         Supplemental Balance Sheet Information - Estimated  HTML     46K 
                Amortization Expense (Details)                                   
75: R60         Supplemental Balance Sheet Information - Accrued    HTML     40K 
                Expenses (Details)                                               
76: R61         Supplemental Balance Sheet Information - Other      HTML     36K 
                Long-Term Liabilities (Details)                                  
77: R62         Business Acquisitions - Narrative (Details)         HTML     57K 
78: R63         Business Acquisitions - Purchase Price Allocation   HTML     71K 
                (Details)                                                        
79: R64         Business Acquisitions - Finite-Lived Intangible     HTML     50K 
                Assets (Details)                                                 
80: R65         Business Acquisitions - Pro-Forma Information       HTML     55K 
                (Details)                                                        
81: R66         Leases - ROU Assets and Lease Liabilities           HTML     42K 
                (Details)                                                        
82: R67         Leases - Cost and Cash Flows From Lease Agreements  HTML     43K 
                (Details)                                                        
83: R68         Leases - Future Minimum Obligations Under           HTML     46K 
                Operating Leases (Details)                                       
84: R69         Fair Value Information (Details)                    HTML     52K 
85: R70         Debt - Debt Balances (Details)                      HTML     55K 
86: R71         Debt - Narratives (Details)                         HTML    103K 
87: R72         Debt - Maturities of Long-Term Debt (Details)       HTML     44K 
88: R73         Income Taxes - Provision for Income Taxes           HTML     70K 
                (Details)                                                        
89: R74         Income Taxes - Narrative (Details)                  HTML     51K 
90: R75         Income Taxes - Reconciliation of Federal Statutory  HTML     61K 
                Rate and Effective Rate (Details)                                
91: R76         Income Taxes - Components of Deferred Tax Assets    HTML     72K 
                and Liabilities (Details)                                        
92: R77         Employee Benefit Plans - Defined Contribution       HTML     32K 
                Plans (Details)                                                  
93: R78         Employee Benefit Plans - Defined Benefit Plans      HTML     39K 
                (Details)                                                        
94: R79         Accumulated Other Comprehensive Income - Changes    HTML     49K 
                in Components of Accumulated Other Comprehensive                 
                Income, net of tax (Details)                                     
95: R80         Accumulated Other Comprehensive Income - Net        HTML     45K 
                Changes in Components of AOCI, Including Tax                     
                Effect (Details)                                                 
96: R81         Stock-Based Compensation - Narrative (Details)      HTML     84K 
97: R82         Stock-Based Compensation - Stock-Based              HTML     49K 
                Compensation Expense (Details)                                   
98: R83         Stock-Based Compensation - Stock Option Activity    HTML     64K 
                (Details)                                                        
99: R84         Stock-Based Compensation - Options Outstanding, by  HTML     56K 
                Exercise Price Range (Details)                                   
100: R85         Stock-Based Compensation - Restricted Stock Units   HTML     54K  
                Activity (Details)                                               
101: R86         Stock-Based Compensation - Performance Shares       HTML     49K  
                Activity (Details)                                               
102: R87         Commitments and Contingencies - Narrative           HTML     36K  
                (Details)                                                        
103: R88         Earnings Per Share ("Eps") (Details)                HTML    100K  
104: R89         Business and Products Information - Narrative       HTML     42K  
                (Details)                                                        
105: R90         Business and Products Information - Net Sales by    HTML     46K  
                Product Category (Details)                                       
106: R91         Business and Products Information - Accrued         HTML     38K  
                Liabilities (Details)                                            
107: R92         Business and Products Information - Property,       HTML     37K  
                plant and equipment (Details)                                    
108: R93         Share Repurchase Program - Narrative (Details)      HTML     37K  
109: R94         Share Repurchase Program - Purchase Activity        HTML     41K  
                (Details)                                                        
111: XML         IDEA XML File -- Filing Summary                      XML    200K  
114: XML         XBRL Instance -- avns-20231231_htm                   XML   2.09M  
110: EXCEL       IDEA Workbook of Financial Report Info              XLSX    142K  
12: EX-101.CAL  XBRL Calculations -- avns-20231231_cal               XML    326K 
13: EX-101.DEF  XBRL Definitions -- avns-20231231_def                XML    755K 
14: EX-101.LAB  XBRL Labels -- avns-20231231_lab                     XML   2.06M 
15: EX-101.PRE  XBRL Presentations -- avns-20231231_pre              XML   1.31M 
11: EX-101.SCH  XBRL Schema -- avns-20231231                         XSD    205K 
112: JSON        XBRL Instance as JSON Data -- MetaLinks              586±   828K  
113: ZIP         XBRL Zipped Folder -- 0001606498-24-000018-xbrl      Zip    466K  


‘EXCEL’   —   IDEA Workbook of Financial Report Info


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


18 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/02/23  Avanos Medical, Inc.              8-K:2,9    10/02/23   11:244K
 8/09/23  Avanos Medical, Inc.              10-Q        6/30/23   77:7.1M
 7/13/23  Avanos Medical, Inc.              S-8         7/13/23    6:270K
 5/03/23  Avanos Medical, Inc.              10-Q        3/31/23   70:5.3M
 2/21/23  Avanos Medical, Inc.              10-K       12/31/22  116:11M
 8/09/22  Avanos Medical, Inc.              10-Q        6/30/22   73:9.6M
 1/21/22  Avanos Medical, Inc.              8-K:2,9     1/20/22   13:3.6M
 8/03/21  Avanos Medical, Inc.              10-Q        6/30/21   65:5.6M
 7/09/21  Avanos Medical, Inc.              8-K:1,9     7/06/21   11:483K
 2/19/21  Avanos Medical, Inc.              10-K       12/31/20  109:11M
11/03/20  Avanos Medical, Inc.              10-Q        9/30/20   69:5.5M
 5/06/20  Avanos Medical, Inc.              8-K:2,5,9   4/30/20   15:920K
12/30/19  Avanos Medical, Inc.              8-K:5,9    12/30/19   14:277K
 8/07/19  Avanos Medical, Inc.              S-8         8/07/19    5:231K
 5/02/18  Avanos Medical, Inc.              10-Q        3/31/18   72:8.3M
10/31/17  Avanos Medical, Inc.              8-K:5,9    10/31/17    3:356K
 6/23/17  Avanos Medical, Inc.              8-K:5,7,9   6/23/17    3:72K
11/04/14  Avanos Medical, Inc.              8-K:1,2,5,810/31/14   19:5.1M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001606498-24-000018   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 7:58:01.1pm ET